ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of the Crucial Role of CCL22 in F. nucleatum-Related Colorectal Tumorigenesis that Correlates With Tumor Microenvironment and Immune Checkpoint Therapy

Wang, Hufei; Luo, Kangjia; Guan, Zilong; Li, Zhi; Xiang, Jun; Ou, Suwen; Tao, Yangbao; Ran, Songlin; Ye, Jinhua; Ma, Tianyi; Qiao, Tianyu; Zhang, Zhiming; Jin, Yinghu*; Song, Yanni*; Huang, Rui*哈尔滨医科大学
Frontiers in Genetics2022-2-28DOI: 10.3389/fgene.2022.811900
9被引5阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is the third most common malignant cancer worldwide with the second highest mortality. Gut microbiota can educate the tumor microenvironment (TME), consequently influencing the efficacy of immune checkpoint inhibitors (ICIs). Fusobacterium nucleatum is one of the most crucial bacteria contributing to colorectal tumorigenesis, but the molecular mechanisms between F. nucleatum and TME or ICIs are poorly investigated. In the present study, we firstly analyzed differentially expressed genes and the biological functions between F. nucleatum-infected and uninfected CRC cell lines, with the findings that CCL22 mRNA expression was markedly upregulated after F. nucleatum infection. Moreover, the survival analysis showed that CCL22 was significantly associated with the overall survival of CRC patients. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis suggested that CCL22 was related to immune-related terms. Furthermore, the ESTIMATE analysis indicated that the high-CCL22-expression subgroup had a higher immune/stromal/estimate score and lower tumor purity. The CIBERSORT analysis indicated that the high-CCL22-expression group had more immune-suppressive cells and less antitumor immune cells. In addition, immune checkpoint genes and cytotoxic genes were positively correlated with CCL22 expression. The immunophenoscore analysis suggested that CCL22 was associated with the IPS-CTLA4 and PD1/PD-L1/PD-L2 score. Interestingly, CCL22 expression in the KRAS and APC mutation groups was markedly reduced compared to that of the wild groups. In summary, our study provided evidence that CCL22 might play a crucial role in F. nucleatum-related colorectal tumorigenesis and correlate with TME and ICIs, which deserves further study.

学科与关键词

关键词
Fusobacterium nucleatumtumor microenvironmentimmune checkpoint therapychemokinesCCL22
相关
加载中…
  • Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
    Ou, Suwen; Wang, Hufei; Tao, Yangbao; Luo, Kangjia; Ye, Jinhua; Ran, Songlin; Guan, Zilong; Wang, Yuliuming; Hu, Hanqing; Huang, Rui*Frontiers in Cellular and Infection Microbiology, 2022, 12: 1020583.被引 10
  • Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis
    Ou, Suwen; Chen, Haipeng; Wang, Hufei; Ye, Jinhua; Liu, Huidi; Tao, Yangbao; Ran, Songlin; Mu, Xiaoqin; Liu, Fangzhou; Zhu, Shuang; Luo, Kangjia; Guan, Zilong; Jin, Yinghu; Huang, Rui*; Song, Yanni*; Liu, Shu-lin*Journal of Translational Medicine, 2023, 21(1): 704.被引 1
  • F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer.
    Hong, Jie*; Guo, Fangfang; Lu, Shi-Yuan; Shen, Chaoqin; Ma, Dan; Zhang, Xinyu; Xie, Yile; Yan, Tingting; Yu, TaChung; Sun, Tiantian; Qian, Yun; Zhong, Ming; Chen, Jinxian; Peng, Yanshen; Wang, Cheng; Zhou, Xiang; Liu, Jianjun; Liu, Qiang; Ma, Xiong; Chen, Ying-Xuan; Chen, Haoyan*; Fang, Jing-Yuan*Gut, 2021, 70(11): 2123-2137.被引 46
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-02-28
卷期
第 13 卷
页码
811900
DOI
10.3389/fgene.2022.811900
期刊等级
3区
成果收录
SCIE

作者

  • W

    Wang, Hufei (第一作者)

    2 · harbin med univ

  • L

    Luo, Kangjia

    2 · harbin med univ

查看全部 15 位作者收起作者
  • G

    Guan, Zilong

    2 · harbin med univ

  • L

    Li, Zhi

    2 · harbin med univ

  • X

    Xiang, Jun

    2 · harbin med univ

  • O

    Ou, Suwen

    2 · harbin med univ

  • T

    Tao, Yangbao

    2 · harbin med univ

  • R

    Ran, Songlin

    2 · harbin med univ

  • Y

    Ye, Jinhua

    2 · harbin med univ

  • M

    Ma, Tianyi

    2 · harbin med univ

  • Q

    Qiao, Tianyu

    2 · harbin med univ

  • Z

    Zhang, Zhiming

    2 · harbin med univ

  • J

    Jin, Yinghu (通讯)

    2 · harbin med univ

  • S

    Song, Yanni (通讯)

    harbin med univ

  • H

    Huang, Rui (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417